Hormone replacement therapy with estrogen
Hormone replacement therapy with estrogen has been studied in 1 paper since 2020: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Apr 7, 2020: “Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis”.
1 paper studies it1 findingUpdated
See all 1 papers on hormone replacement therapy with estrogen
At a glance
The findings reach people, from one lab or study. 1 lab in 2 countries.
- 1 lab in 2 countries
What is hormone replacement therapy with estrogen linked with?
1Studies link hormone replacement therapy with estrogen with fragility hip fracture.
Fragility hip fracture
downin humans1OR 0.8
1 study
Fragility hip fracture
downin humans1OR 0.8
Hormone replacement therapy with estrogen lowers the risk of fragility hip fracture in humans (OR 0.80, 95% CI 0.65-0.98).
“Hormone replacement therapy with estrogen (HRT) was associated with decreased risk of hip fracture (OR 0.80, 95% CI 0.65-0.98).”
Review
Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis
Calcified tissue international